| Amgen (AMGN) |
United States |
$108.245B |
12.24 |
| Gilead Sciences (GILD) |
United States |
$85.342B |
10.36 |
| Celgene (CELG) |
United States |
$64.552B |
10.94 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$45.118B |
54.54 |
| Biogen (BIIB) |
United States |
$44.896B |
8.52 |
| Illumina (ILMN) |
United States |
$44.438B |
51.50 |
| CSL (CSLLY) |
Australia |
$35.409B |
0.00 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$32.605B |
15.32 |
| Actelion (ALIOF) |
Switzerland |
$29.891B |
0.00 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$27.541B |
15.59 |
| Incyte (INCY) |
United States |
$17.129B |
69.46 |
| Exact Sciences (EXAS) |
United States |
$14.845B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$14.750B |
0.00 |
| SINO PHARMACEUT (SBMFF) |
China |
$14.154B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$11.364B |
0.00 |
| Genmab (GNMSF) |
Denmark |
$11.067B |
56.26 |
| Array BioPharma (ARRY) |
United States |
$10.346B |
0.00 |
| Seattle Genetics (SGEN) |
United States |
$10.192B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$9.283B |
49.21 |
| QIAGEN (QGEN) |
Netherlands |
$8.908B |
29.26 |
| Galapagos (GLPG) |
Belgium |
$8.802B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$7.964B |
54.34 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$7.909B |
0.00 |
| Guardant Health (GH) |
United States |
$7.720B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$7.368B |
0.00 |
| Amarin (AMRN) |
Ireland |
$7.189B |
0.00 |
| Exelixis (EXEL) |
United States |
$6.482B |
16.52 |
| BeiGene (BGNE) |
Cayman Islands |
$5.652B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$4.867B |
0.00 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$4.719B |
0.00 |
| Moderna (MRNA) |
United States |
$4.652B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$4.628B |
0.00 |
| Horizon Pharma Public (HZNP) |
Ireland |
$4.408B |
11.35 |
| Repligen (RGEN) |
United States |
$4.177B |
104.05 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$3.787B |
0.00 |
| Spark Therapeutics (ONCE) |
United States |
$3.752B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$3.729B |
0.00 |
| China Biologic Products (CBPO) |
China |
$3.682B |
23.39 |
| Alkermes (ALKS) |
Ireland |
$3.668B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$3.401B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$3.316B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$3.062B |
6.22 |
| Amicus Therapeutics (FOLD) |
United States |
$2.899B |
0.00 |
| Immunomedics (IMMU) |
United States |
$2.772B |
0.00 |
| Medicines (MDCO) |
United States |
$2.740B |
0.00 |
| UniQure (QURE) |
Netherlands |
$2.631B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$2.613B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$2.566B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$2.468B |
0.00 |
| MyoKardia (MYOK) |
United States |
$2.308B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$2.299B |
19.04 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$2.251B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$2.231B |
19.38 |
| NeoGenomics (NEO) |
United States |
$2.216B |
145.06 |
| Acceleron Pharma (XLRN) |
United States |
$2.160B |
0.00 |
| Zai Lab (ZLAB) |
China |
$2.106B |
0.00 |
| Genomic Health (GHDX) |
United States |
$2.078B |
44.13 |
| Akcea Therapeutics (AKCA) |
United States |
$2.072B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$2.046B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$1.911B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$1.907B |
18.97 |
| REGENXBIO (RGNX) |
United States |
$1.720B |
0.00 |
| Insmed (INSM) |
United States |
$1.690B |
0.00 |
| Cambrex (CBM) |
United States |
$1.501B |
18.98 |
| Fate Therapeutics (FATE) |
United States |
$1.464B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$1.431B |
0.00 |
| RA PHARMCTL INC (RARX) |
United States |
$1.421B |
0.00 |
| Innoviva (INVA) |
United States |
$1.405B |
3.89 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.349B |
0.00 |
| Athenex (ATNX) |
United States |
$1.329B |
0.00 |
| Alector (ALEC) |
United States |
$1.311B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.284B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$1.198B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$1.185B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.174B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$1.036B |
0.00 |
| Codexis (CDXS) |
United States |
$1.031B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$1.013B |
0.00 |
| Momenta Pharmaceuticals (MNTA) |
United States |
$1.013B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$0.979B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.976B |
17.31 |
| Twist Bioscience (TWST) |
United States |
$0.963B |
0.00 |
| Principia Biopharma (PRNB) |
United States |
$0.955B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$0.940B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.928B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.924B |
0.00 |
| Retrophin (RTRX) |
United States |
$0.873B |
0.00 |
| Alder BioPharmaceuticals (ALDR) |
United States |
$0.873B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$0.856B |
0.00 |
| Vericel (VCEL) |
United States |
$0.854B |
0.00 |
| Arvinas (ARVN) |
United States |
$0.811B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$0.755B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.712B |
33.60 |
| Precision BioSciences (DTIL) |
United States |
$0.699B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$0.683B |
7.99 |
| Zealand Pharma (ZLDPF) |
Denmark |
$0.683B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.678B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$0.668B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.647B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.640B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$0.640B |
0.00 |
| Heska (HSKA) |
United States |
$0.617B |
63.16 |
| DBV Technologies S.A (DBVT) |
France |
$0.604B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.589B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.579B |
19.79 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.575B |
0.00 |
| Stemline Therapeutics (STML) |
United States |
$0.568B |
0.00 |
| MiMedx (MDXG) |
United States |
$0.546B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$0.542B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.537B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.521B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.504B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$0.454B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.447B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.442B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.417B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.386B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.385B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.379B |
9.06 |
| AC Immune SA (ACIU) |
Switzerland |
$0.377B |
24.26 |
| Arcus Biosciences (RCUS) |
United States |
$0.376B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.373B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.371B |
0.00 |
| Bellus Health (BLUSF) |
Canada |
$0.366B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.365B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$0.359B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.359B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.359B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.356B |
0.00 |
| Prometic Life Sciences (PFSCD) |
Canada |
$0.348B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.346B |
0.00 |
| Agenus (AGEN) |
United States |
$0.344B |
0.00 |
| Achillion Pharmaceuticals (ACHN) |
United States |
$0.343B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.340B |
0.00 |
| Senesco Technologies (ELOX) |
United States |
$0.337B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.331B |
5.83 |
| Kadmon Holdings (KDMN) |
United States |
$0.329B |
0.00 |
| Theratechnologies (THERF) |
Canada |
$0.328B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.324B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.309B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$0.308B |
0.00 |
| AMAG Pharmaceuticals (AMAG) |
United States |
$0.304B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$0.294B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.270B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.269B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.263B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.262B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.261B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.260B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.252B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.247B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.238B |
9.22 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.233B |
0.00 |
| Athersys (ATHX) |
United States |
$0.232B |
0.00 |
| Geron (GERN) |
United States |
$0.226B |
0.00 |
| Palatin Technologies (PTN) |
United States |
$0.222B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.221B |
0.00 |
| Cel-Sci (CVM) |
United States |
$0.220B |
0.00 |
| Cerecor (CERC) |
United States |
$0.210B |
0.00 |
| MannKind (MNKD) |
United States |
$0.205B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.204B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.198B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.198B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.196B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.195B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.191B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.186B |
0.00 |
| Pfenex (PFNX) |
United States |
$0.186B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.185B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
|
$0.184B |
0.00 |
| Arsanis (XFOR) |
United States |
$0.183B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.182B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.178B |
0.00 |
| BioTime (BTX) |
United States |
$0.177B |
11.80 |
| Newron Pharmaceuticals SpA (NWPHF) |
|
$0.165B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.163B |
0.00 |
| XOMA (XOMA) |
United States |
$0.158B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.157B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.150B |
8.63 |
| OvaScience (MLND) |
United States |
$0.148B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.148B |
0.00 |
| TOCAGEN INC (TOCA) |
United States |
$0.142B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.140B |
0.00 |
| Adocia (ADOCY) |
France |
$0.140B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.140B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$0.135B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.134B |
0.00 |
| NantKwest (NK) |
United States |
$0.127B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.125B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.123B |
0.00 |
| Alcobra (ARCT) |
United States |
$0.120B |
0.00 |
| Arbutus Biopharma (ABUS) |
Canada |
$0.119B |
0.00 |
| Aduro Biotech (ADRO) |
United States |
$0.119B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.119B |
0.00 |
| Menlo Therapeutics (MNLO) |
United States |
$0.118B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.117B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.116B |
0.00 |
| Verastem (VSTM) |
United States |
$0.114B |
0.00 |
| Novavax (NVAX) |
United States |
$0.109B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.103B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.103B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.103B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.100B |
0.00 |
| Trevena (TRVN) |
United States |
$0.097B |
0.00 |
| Curis (CRIS) |
United States |
$0.094B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.093B |
0.00 |
| Catabasis Pharmaceuticals (CATB) |
United States |
$0.085B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.084B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.084B |
0.00 |
| Spring Bank Pharmaceuticals (SBPH) |
United States |
$0.083B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.083B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.082B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.081B |
0.00 |
| Unum Therapeutics (UMRX) |
United States |
$0.079B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.078B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.075B |
0.00 |
| Merrimack Pharmaceuticals (MACK) |
United States |
$0.073B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.073B |
0.00 |
| Signal Genetics (MGEN) |
United States |
$0.072B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.072B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.069B |
37.90 |
| Organovo Holdings (ONVO) |
United States |
$0.067B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.063B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.062B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.062B |
0.00 |
| Protalix BioTherapeutics (PLX) |
Israel |
$0.060B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.060B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.059B |
0.00 |
| Invo BioScience (IVOB) |
United States |
$0.057B |
0.00 |
| NewLink Genetics (NLNK) |
United States |
$0.054B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.053B |
0.00 |
| Ophthotech (ISEE) |
United States |
$0.051B |
0.00 |
| Proteostasis Therapeutics (PTI) |
United States |
$0.050B |
0.00 |
